We require patients with Chronic Kidney Disease for a new study.
Participation in the study could last up to 4 years. This study will be approx. 22 visits to the unit during the first 2 years, then visits every 8 weeks for the rest of the treatment period and a 28 day follow up period.
A payment of up to £70 per visit will be made on completion of the study for your time and to compensate for any inconvenience. Travel expenses will also be paid.
If you would like to find out more about this study please call our Recruitment Team on 0800 655 6553 OR 0161 946 4050 and quote study 432, or register your interest below.
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations. Learn more at www.iqvia.com.
Contact us…
The Medicines Evaluation Unit
The Langley Building
Southmoor Road
Wythenshawe Hospital
Manchester
M23 9QZ
T: 0800 655 6553